Moreover, Pan et al. reported that BM-MSCs were able to attenuate liver fibrosis via the direct suppression of hepatic stellate cell activation through the inhibition of delta-like 1 protein, a member of the EGF-like family of homeotic proteins, in a CCL4-induced liver fibrosis animal model [46]. This evidence concerns the gene CCL4 and Hepatic fibrosis.